Sensitization of glioma cells to tamoxifen-induced apoptosis by Pl3-kinase inhibitor through the GSK-3β/β-catenin signaling pathway.
Malignant gliomas represent one of the most aggressive types of cancers and their recurrence is closely linked to acquired therapeutic resistance. A combination of chemotherapy is considered a promising therapeutic model in overcoming therapeutic resistance and enhancing treatment efficacy. Herein,...
Main Authors: | Cuixian Li, Chun Zhou, Shaogui Wang, Ying Feng, Wei Lin, Sisi Lin, Ying Wang, Heqing Huang, Peiqing Liu, Yong-Gao Mu, Xiaoyan Shen |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2011-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3203172?pdf=render |
Similar Items
-
GSK3β and β-Catenin Modulate Radiation Cytotoxicity in Pancreatic Cancer
by: Richard L. Watson, et al.
Published: (2010-05-01) -
ROLE OF GSK-3 IN Wnt/β-CATENIN SIGNALING PATHWAY IN OBESITY
by: A. S. Kulakova, et al.
Published: (2021-10-01) -
Effects of rotenone exposure during pregnancy on GSK-3β and β-catenin protein expression in rat placenta
by: Ziwei DENG, et al.
Published: (2023-04-01) -
FAK/PYK2 promotes the Wnt/β-catenin pathway and intestinal tumorigenesis by phosphorylating GSK3β
by: Chenxi Gao, et al.
Published: (2015-08-01) -
Roles of GSK-3 and β-Catenin in Antiviral Innate Immune Sensing of Nucleic Acids
by: Alexandre Marineau, et al.
Published: (2020-04-01)